Chemical and colloidal stability of carboxylated core-shell magnetite nanoparticles designed for biomedical applications.

Szekeres, Márta and Tóth, Ildikó Y and Illés, Erzsébet and Hajdú, Angéla and Zupkó, István and Farkas, Katalin and Oszlánczi, Gábor and Tiszlavicz, László and Tombácz, Etelka (2013) Chemical and colloidal stability of carboxylated core-shell magnetite nanoparticles designed for biomedical applications. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 14 (7). pp. 14550-74. ISSN 1422-0067

Preview

Text Szekeres_IJMS_2013_14_14550.pdf Download (2MB) | Preview

Abstract

Despite the large efforts to prepare super paramagnetic iron oxide nanoparticles (MNPs) for biomedical applications, the number of FDA or EMA approved formulations is few. It is not known commonly that the approved formulations in many instances have already been withdrawn or discontinued by the producers; at present, hardly any approved formulations are produced and marketed. Literature survey reveals that there is a lack for a commonly accepted physicochemical practice in designing and qualifying formulations before they enter in vitro and in vivo biological testing. Such a standard procedure would exclude inadequate formulations from clinical trials thus improving their outcome. Here we present a straightforward route to assess eligibility of carboxylated MNPs for biomedical tests applied for a series of our core-shell products, i.e., citric acid, gallic acid, poly(acrylic acid) and poly(acrylic acid-co-maleic acid) coated MNPs. The discussion is based on physicochemical studies (carboxylate adsorption/desorption, FTIR-ATR, iron dissolution, zeta potential, particle size, coagulation kinetics and magnetization measurements) and involves in vitro and in vivo tests. Our procedure can serve as an example to construct adequate physico-chemical selection strategies for preparation of other types of core-shell nanoparticles as well.

Actions (login required)

Edit Item